Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Twelve states have an adult obesity prevalence of 35% or more.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
“Will we have a COVID vaccine next year tailored to the obese? No way."
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
This finding held true regardless of individuals’ initial weight, unless they had obesity, in a recent large study.
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
Newer drug classes are tied to a higher risk of weight gain, which is more likely to occur among Black women in particular.
Researchers at George Washington University take a look.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
HIV is associated with an elevated risk of diabetes.
Researchers have for the first time properly assessed HIV’s association with this health outcome.
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
More high-quality evidence is needed to determine how this class of HIV medications may affect weight gain.
A large, ongoing study of people with HIV found that only a couple of older antiretrovirals were linked to high blood pressure.
People with HIV may be more likely to develop diabetes and to do so at a younger age, even if they are not obese.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.